Motor score of the unified Parkinson disease rating scale as a good predictor of lewy body-associated neuronal loss in the substantia nigra

Archives of Neurology

Volumn 63, Issue 4, 2006, Pages 584-588

  Greffard, Sandrine ^a   Verny, Marc ^a,e   Bonnet, Anne Marie ^b,d   Beinis, Jean Yves ^f   Gallinari, Claude ^f   Meaume, Sylvie ^f   Piette, François ^e,f   Hauw, Jean Jacques ^c,e   Duyckaerts, Charles ^c,d,e,g  

^a Geriatric Center   (France)

^b Neurology Department   (France)

^c Laboratoire de Neuropathologie   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f HÔPITAL CHARLES FOIX   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ARTICLE; AUTOPSY; BRAIN NERVE CELL; CELL DENSITY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HEALTH CARE FACILITY; HUMAN; LEWY BODY; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; LONGITUDINAL STUDY; MALE; MATHEMATICAL MODEL; MOTOR ACTIVITY; NERVE CELL LESION; PARKINSONISM; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; REGRESSION ANALYSIS; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; CELL COUNT; FEMALE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; LONGITUDINAL STUDIES; MALE; MOVEMENT; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; NEURONS; PARKINSONIAN DISORDERS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STATISTICS; SUBSTANTIA NIGRA;

EID: 33645749795     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.4.584     Document Type: Article

References (19)

1. Fahn S, Elton R; UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163.
2. Ross GW, Petrovitch H, Abbott RD, et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol. 2004;56:532-539.
3. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991;114:2283-2301.
4. 18F]dopa PET. J Neurol Neurosurg Psychiatry. 1998;64:314-319.
5. Hilker R, Schweitzer K, Coburger S, et al. Nonlinear progression of Parkinsondisease as determined by serial positron emission tomographic imaging of striatal fluorodopa F18 activity. Arch Neurol. 2005;62:378-382.
6. Ramaker C, Marinus J, Stiggelbout A, Van Hilten B. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord. 2002;17:867-876.
7. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
9. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
10. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239-259.
11. Grignon Y, Duyckaerts C, Bennecib M, Hauw J-J. Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neuropathol (Berl). 1998;95:395-406.
12. Duyckaerts C, Godefroy G, Hauw J-J. Evaluation of neuronal numerical density by Dirichlet tessellation. J Neurosci Methods. 1994;51:47-69.
13. Serra J. Image Analysis and Mathematical Morphology. Orlando, Fla: Academic Press Inc; 1982.
14. Abercrombie M. Estimation of nuclear populations from microtome sections. Anat Rec. 1946;94:239-247.
15. Ma SY, Roytta M, Rinne JO, Collan Y, Rinne UK. Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease. Neuropathol Appl Neurobiol. 1995;21:341-343.
16. Ma SY, Roytta M, Rinne JO, Collan Y, Rinne UK. Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts. J Neurol Sci. 1997;151:83-87.
17. Rinne JO, Rummukainen J, Paljarvi L, Rinne U. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol. 1989;26:47-50.
18. Burn DJ, Rowan EN, Minett T, et al. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord. 2003;18:884-889.
19. Jankovic J. Progression of Parkinson disease: are we making progress in charting the course? Arch Neurol. 2005;62:351-352.